Css LLC Curis Inc Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $13,707 - $46,916	-19,307 Reduced 54.24%	16,290 $16,000
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $43,652 - $55,666	6,290 Added 21.46%	35,597 $279,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $63,392 - $138,441	8,509 Added 40.91%	29,307 $237,000
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $131,700 - $192,000	-15,000 Reduced 41.9%	20,798 $235,000
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $38,661 - $293,543	35,798 New	35,798 $293,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.